awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58801181-FDBB9566-A057-450F-9F19-B08E9883606B
Q58801181-FDBB9566-A057-450F-9F19-B08E9883606B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58801181-FDBB9566-A057-450F-9F19-B08E9883606B
Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
P2860
Q58801181-FDBB9566-A057-450F-9F19-B08E9883606B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58801181-FDBB9566-A057-450F-9F19-B08E9883606B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b4e240d0722f0671065b9c112e62c9a2b75bdffd
P2860
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-